HEADER HYDROLASE/ANTIBIOTIC 16-JUN-11 3SH8 TITLE CRYSTAL STRUCTURE OF FLUOROPHORE-LABELED BETA-LACTAMASE PENP IN TITLE 2 COMPLEX WITH CEPHALORIDINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-LACTAMASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: SMALL EXOPENICILLINASE; COMPND 5 SYNONYM: PENICILLINASE; COMPND 6 EC: 3.5.2.6; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS LICHENIFORMIS; SOURCE 3 ORGANISM_TAXID: 1402; SOURCE 4 GENE: PENP; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS BETA-LACTAMASE, FLUOROPHORE, CEPHALORIDINE, HYDROLASE-ANTIBIOTIC KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR W.-T.WONG,Y.-X.ZHAO,Y.-C.LEUNG REVDAT 4 20-MAR-24 3SH8 1 REMARK SEQADV REVDAT 3 19-JUN-13 3SH8 1 JRNL REVDAT 2 10-AUG-11 3SH8 1 HETSYN REVDAT 1 27-JUL-11 3SH8 0 SPRSDE 27-JUL-11 3SH8 3KGO JRNL AUTH W.-T.WONG,K.-C.CHAN,P.-K.SO,H.-K.YAP,W.-H.CHUNG,Y.-C.LEUNG, JRNL AUTH 2 K.-Y.WONG,Y.-X.ZHAO JRNL TITL INCREASED STRUCTURAL FLEXIBILITY AT THE ACTIVE SITE OF A JRNL TITL 2 FLUOROPHORE-CONJUGATED BETA-LACTAMASE DISTINCTIVELY IMPACTS JRNL TITL 3 ITS BINDING TOWARD DIVERSE CEPHALOSPORIN ANTIBIOTICS JRNL REF J.BIOL.CHEM. V. 286 31771 2011 JRNL REFN ISSN 0021-9258 JRNL PMID 21705325 JRNL DOI 10.1074/JBC.M110.198895 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0072 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.60 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 31836 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.228 REMARK 3 R VALUE (WORKING SET) : 0.225 REMARK 3 FREE R VALUE : 0.267 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1752 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2347 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.96 REMARK 3 BIN R VALUE (WORKING SET) : 0.2500 REMARK 3 BIN FREE R VALUE SET COUNT : 132 REMARK 3 BIN FREE R VALUE : 0.3010 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3941 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 44 REMARK 3 SOLVENT ATOMS : 342 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.16 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.08000 REMARK 3 B22 (A**2) : 0.08000 REMARK 3 B33 (A**2) : -0.01000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.01000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.202 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.143 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.068 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.925 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.895 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4043 ; 0.011 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5455 ; 2.201 ; 1.992 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 493 ; 6.674 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 182 ;34.631 ;24.835 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 728 ;16.173 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ;17.379 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 630 ; 0.194 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2986 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2513 ; 0.490 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4035 ; 0.895 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1530 ; 0.838 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1420 ; 1.463 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3SH8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 06-JUL-11. REMARK 100 THE DEPOSITION ID IS D_1000066198. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 291 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR REMARK 200 DATA SCALING SOFTWARE : CRYSTALCLEAR REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46065 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.790 REMARK 200 RESOLUTION RANGE LOW (A) : 64.060 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASES REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.57 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG4000, PH 7.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 45.86500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 25 REMARK 465 LYS A 26 REMARK 465 THR A 27 REMARK 465 GLU A 28 REMARK 465 MET A 29 REMARK 465 LEU A 169 REMARK 465 ASN A 170 REMARK 465 GLU A 171 REMARK 465 VAL A 172 REMARK 465 MET A 292 REMARK 465 ASN A 293 REMARK 465 GLY A 294 REMARK 465 LYS A 295 REMARK 465 MET B 25 REMARK 465 LYS B 26 REMARK 465 THR B 27 REMARK 465 GLU B 28 REMARK 465 MET B 29 REMARK 465 LYS B 30 REMARK 465 LEU B 169 REMARK 465 ASN B 170 REMARK 465 GLU B 171 REMARK 465 VAL B 172 REMARK 465 MET B 292 REMARK 465 ASN B 293 REMARK 465 GLY B 294 REMARK 465 LYS B 295 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 30 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 70 C8 CED A 1 1.90 REMARK 500 OG SER B 70 C8 CED B 1 2.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLN A 83 C LYS A 86 N 0.145 REMARK 500 ASN A 173 N ASN A 173 CA 0.136 REMARK 500 VAL B 57 C ALA B 59 N 0.191 REMARK 500 GLN B 83 C LYS B 86 N 0.192 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 252 O - C - N ANGL. DEV. = -11.9 DEGREES REMARK 500 PRO A 254 C - N - CD ANGL. DEV. = -23.3 DEGREES REMARK 500 PRO B 167 C - N - CD ANGL. DEV. = -14.1 DEGREES REMARK 500 TRP B 251 O - C - N ANGL. DEV. = -11.6 DEGREES REMARK 500 PRO B 254 C - N - CD ANGL. DEV. = -16.9 DEGREES REMARK 500 PRO B 254 O - C - N ANGL. DEV. = -10.4 DEGREES REMARK 500 LYS B 255 C - N - CA ANGL. DEV. = 16.7 DEGREES REMARK 500 ASN B 291 N - CA - C ANGL. DEV. = 20.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 69 -137.41 49.25 REMARK 500 VAL A 103 -139.33 -121.95 REMARK 500 GLU A 163 -35.67 -136.61 REMARK 500 CYS A 166 -51.13 91.35 REMARK 500 PRO A 167 -85.33 -67.29 REMARK 500 GLU A 196 -131.22 -105.76 REMARK 500 LEU A 220 -120.49 -103.50 REMARK 500 PRO A 254 -77.50 6.55 REMARK 500 ALA B 69 -137.95 49.37 REMARK 500 VAL B 103 -143.93 -122.24 REMARK 500 CYS B 166 170.82 79.79 REMARK 500 PRO B 167 -128.52 6.66 REMARK 500 GLU B 196 -139.94 -98.39 REMARK 500 LEU B 220 -127.59 -107.29 REMARK 500 PRO B 254 -70.58 16.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PHE B 165 CYS B 166 -149.47 REMARK 500 CYS B 166 PRO B 167 43.63 REMARK 500 PRO B 167 GLU B 168 -44.40 REMARK 500 LEU B 290 ASN B 291 149.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 PRO A 252 13.92 REMARK 500 VAL B 57 13.61 REMARK 500 ALA B 238 -10.10 REMARK 500 PRO B 252 20.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CED A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CED B 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3SH7 RELATED DB: PDB REMARK 900 RELATED ID: 3SH9 RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 SOME RESIDUE NUMBERS ARE SIMPLY SKIPPED. DBREF 3SH8 A 26 295 UNP P00808 BLAC_BACLI 43 307 DBREF 3SH8 B 26 295 UNP P00808 BLAC_BACLI 43 307 SEQADV 3SH8 MET A 25 UNP P00808 INITIATING METHIONINE SEQADV 3SH8 CYS A 166 UNP P00808 GLU 180 ENGINEERED MUTATION SEQADV 3SH8 MET B 25 UNP P00808 INITIATING METHIONINE SEQADV 3SH8 CYS B 166 UNP P00808 GLU 180 ENGINEERED MUTATION SEQRES 1 A 266 MET LYS THR GLU MET LYS ASP ASP PHE ALA LYS LEU GLU SEQRES 2 A 266 GLU GLN PHE ASP ALA LYS LEU GLY ILE PHE ALA LEU ASP SEQRES 3 A 266 THR GLY THR ASN ARG THR VAL ALA TYR ARG PRO ASP GLU SEQRES 4 A 266 ARG PHE ALA PHE ALA SER THR ILE LYS ALA LEU THR VAL SEQRES 5 A 266 GLY VAL LEU LEU GLN GLN LYS SER ILE GLU ASP LEU ASN SEQRES 6 A 266 GLN ARG ILE THR TYR THR ARG ASP ASP LEU VAL ASN TYR SEQRES 7 A 266 ASN PRO ILE THR GLU LYS HIS VAL ASP THR GLY MET THR SEQRES 8 A 266 LEU LYS GLU LEU ALA ASP ALA SER LEU ARG TYR SER ASP SEQRES 9 A 266 ASN ALA ALA GLN ASN LEU ILE LEU LYS GLN ILE GLY GLY SEQRES 10 A 266 PRO GLU SER LEU LYS LYS GLU LEU ARG LYS ILE GLY ASP SEQRES 11 A 266 GLU VAL THR ASN PRO GLU ARG PHE CYS PRO GLU LEU ASN SEQRES 12 A 266 GLU VAL ASN PRO GLY GLU THR GLN ASP THR SER THR ALA SEQRES 13 A 266 ARG ALA LEU VAL THR SER LEU ARG ALA PHE ALA LEU GLU SEQRES 14 A 266 ASP LYS LEU PRO SER GLU LYS ARG GLU LEU LEU ILE ASP SEQRES 15 A 266 TRP MET LYS ARG ASN THR THR GLY ASP ALA LEU ILE ARG SEQRES 16 A 266 ALA GLY VAL PRO ASP GLY TRP GLU VAL ALA ASP LYS THR SEQRES 17 A 266 GLY ALA ALA SER TYR GLY THR ARG ASN ASP ILE ALA ILE SEQRES 18 A 266 ILE TRP PRO PRO LYS GLY ASP PRO VAL VAL LEU ALA VAL SEQRES 19 A 266 LEU SER SER ARG ASP LYS LYS ASP ALA LYS TYR ASP ASP SEQRES 20 A 266 LYS LEU ILE ALA GLU ALA THR LYS VAL VAL MET LYS ALA SEQRES 21 A 266 LEU ASN MET ASN GLY LYS SEQRES 1 B 266 MET LYS THR GLU MET LYS ASP ASP PHE ALA LYS LEU GLU SEQRES 2 B 266 GLU GLN PHE ASP ALA LYS LEU GLY ILE PHE ALA LEU ASP SEQRES 3 B 266 THR GLY THR ASN ARG THR VAL ALA TYR ARG PRO ASP GLU SEQRES 4 B 266 ARG PHE ALA PHE ALA SER THR ILE LYS ALA LEU THR VAL SEQRES 5 B 266 GLY VAL LEU LEU GLN GLN LYS SER ILE GLU ASP LEU ASN SEQRES 6 B 266 GLN ARG ILE THR TYR THR ARG ASP ASP LEU VAL ASN TYR SEQRES 7 B 266 ASN PRO ILE THR GLU LYS HIS VAL ASP THR GLY MET THR SEQRES 8 B 266 LEU LYS GLU LEU ALA ASP ALA SER LEU ARG TYR SER ASP SEQRES 9 B 266 ASN ALA ALA GLN ASN LEU ILE LEU LYS GLN ILE GLY GLY SEQRES 10 B 266 PRO GLU SER LEU LYS LYS GLU LEU ARG LYS ILE GLY ASP SEQRES 11 B 266 GLU VAL THR ASN PRO GLU ARG PHE CYS PRO GLU LEU ASN SEQRES 12 B 266 GLU VAL ASN PRO GLY GLU THR GLN ASP THR SER THR ALA SEQRES 13 B 266 ARG ALA LEU VAL THR SER LEU ARG ALA PHE ALA LEU GLU SEQRES 14 B 266 ASP LYS LEU PRO SER GLU LYS ARG GLU LEU LEU ILE ASP SEQRES 15 B 266 TRP MET LYS ARG ASN THR THR GLY ASP ALA LEU ILE ARG SEQRES 16 B 266 ALA GLY VAL PRO ASP GLY TRP GLU VAL ALA ASP LYS THR SEQRES 17 B 266 GLY ALA ALA SER TYR GLY THR ARG ASN ASP ILE ALA ILE SEQRES 18 B 266 ILE TRP PRO PRO LYS GLY ASP PRO VAL VAL LEU ALA VAL SEQRES 19 B 266 LEU SER SER ARG ASP LYS LYS ASP ALA LYS TYR ASP ASP SEQRES 20 B 266 LYS LEU ILE ALA GLU ALA THR LYS VAL VAL MET LYS ALA SEQRES 21 B 266 LEU ASN MET ASN GLY LYS HET CED A 1 22 HET CED B 1 22 HETNAM CED 5-METHYL-2-[2-OXO-1-(2-THIOPHEN-2-YL-ACETYLAMINO)- HETNAM 2 CED ETHYL]-3,6-DIHYDRO-2H-[1,3]THIAZINE-4-CARBOXYLIC ACID HETSYN CED DEGRADED CEPHALORIDINE, OPEN FORM FORMUL 3 CED 2(C14 H16 N2 O4 S2) FORMUL 5 HOH *342(H2 O) HELIX 1 1 LYS A 30 ASP A 41 1 12 HELIX 2 2 THR A 71 LYS A 86 1 14 HELIX 3 3 ILE A 88 ASN A 92 5 5 HELIX 4 4 THR A 98 LEU A 102 5 5 HELIX 5 5 ILE A 108 HIS A 112 5 5 HELIX 6 6 LEU A 119 SER A 130 1 12 HELIX 7 7 ASP A 131 GLY A 143 1 13 HELIX 8 8 GLY A 144 ILE A 155 1 12 HELIX 9 9 THR A 182 LEU A 195 1 14 HELIX 10 10 PRO A 200 ARG A 213 1 14 HELIX 11 11 LEU A 220 VAL A 225 5 6 HELIX 12 12 ASP A 275 ASN A 291 1 17 HELIX 13 13 ASP B 31 ASP B 41 1 11 HELIX 14 14 THR B 71 LYS B 86 1 14 HELIX 15 15 GLU B 89 ASN B 92 5 4 HELIX 16 16 THR B 98 LEU B 102 5 5 HELIX 17 17 LEU B 119 SER B 130 1 12 HELIX 18 18 ASP B 131 GLY B 143 1 13 HELIX 19 19 GLY B 143 ILE B 155 1 13 HELIX 20 20 THR B 182 LEU B 195 1 14 HELIX 21 21 PRO B 200 ARG B 213 1 14 HELIX 22 22 LEU B 220 VAL B 225 5 6 HELIX 23 23 ASP B 276 ASN B 291 1 16 SHEET 1 A 5 THR A 56 TYR A 60 0 SHEET 2 A 5 LYS A 43 ASP A 50 -1 N ILE A 46 O TYR A 60 SHEET 3 A 5 VAL A 259 SER A 266 -1 O LEU A 264 N GLY A 45 SHEET 4 A 5 THR A 243 TRP A 251 -1 N ILE A 250 O VAL A 259 SHEET 5 A 5 GLU A 230 ALA A 238 -1 N GLU A 230 O TRP A 251 SHEET 1 B 2 PHE A 66 ALA A 67 0 SHEET 2 B 2 THR A 180 SER A 181 -1 O SER A 181 N PHE A 66 SHEET 1 C 2 ARG A 94 ILE A 95 0 SHEET 2 C 2 MET A 117 THR A 118 -1 O MET A 117 N ILE A 95 SHEET 1 D 5 THR B 56 TYR B 60 0 SHEET 2 D 5 LYS B 43 ASP B 50 -1 N ILE B 46 O TYR B 60 SHEET 3 D 5 VAL B 259 SER B 266 -1 O SER B 266 N LYS B 43 SHEET 4 D 5 THR B 243 TRP B 251 -1 N ILE B 250 O VAL B 259 SHEET 5 D 5 GLU B 230 ALA B 238 -1 N GLY B 236 O ASN B 245 SHEET 1 E 2 PHE B 66 ALA B 67 0 SHEET 2 E 2 THR B 180 SER B 181 -1 O SER B 181 N PHE B 66 SHEET 1 F 2 ARG B 94 ILE B 95 0 SHEET 2 F 2 MET B 117 THR B 118 -1 O MET B 117 N ILE B 95 CISPEP 1 CYS A 166 PRO A 167 0 -16.72 CISPEP 2 PRO A 167 GLU A 168 0 18.73 CISPEP 3 PRO A 174 GLY A 175 0 0.02 CISPEP 4 GLN A 178 ASP A 179 0 -9.56 CISPEP 5 ASN B 173 PRO B 174 0 -0.46 SITE 1 AC1 12 ALA A 69 SER A 70 ASN A 104 SER A 130 SITE 2 AC1 12 ASN A 132 GLU A 168 LYS A 234 THR A 235 SITE 3 AC1 12 GLY A 236 ALA A 237 ARG A 244 HOH A 399 SITE 1 AC2 11 ALA B 69 SER B 70 ASN B 104 SER B 130 SITE 2 AC2 11 ASN B 132 GLU B 168 THR B 235 GLY B 236 SITE 3 AC2 11 ALA B 237 ARG B 244 HOH B 322 CRYST1 43.330 91.730 66.110 90.00 104.00 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023079 0.000000 0.005754 0.00000 SCALE2 0.000000 0.010902 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015589 0.00000